000 | 01515 a2200409 4500 | ||
---|---|---|---|
005 | 20250513132109.0 | ||
264 | 0 | _c19980130 | |
008 | 199801s 0 0 eng d | ||
022 | _a0022-2275 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHinson, D D | |
245 | 0 | 0 |
_aPost-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways. _h[electronic resource] |
260 |
_bJournal of lipid research _cNov 1997 |
||
300 |
_a2216-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCarboxy-Lyases _xgenetics |
650 | 0 | 4 |
_aCholesterol _xbiosynthesis |
650 | 0 | 4 |
_aDolichol Phosphates _xpharmacology |
650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aEscherichia coli |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aMevalonic Acid _xmetabolism |
650 | 0 | 4 |
_aPhosphotransferases (Alcohol Group Acceptor) _xantagonists & inhibitors |
650 | 0 | 4 |
_aPhosphotransferases (Phosphate Group Acceptor) _xantagonists & inhibitors |
650 | 0 | 4 |
_aPolyisoprenyl Phosphates _xpharmacology |
650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
650 | 0 | 4 | _aSesquiterpenes |
650 | 0 | 4 |
_aTerpenes _xmetabolism |
700 | 1 | _aChambliss, K L | |
700 | 1 | _aToth, M J | |
700 | 1 | _aTanaka, R D | |
700 | 1 | _aGibson, K M | |
773 | 0 |
_tJournal of lipid research _gvol. 38 _gno. 11 _gp. 2216-23 |
|
999 |
_c9362173 _d9362173 |